All medical device manufacturers strive to ensure devices and biomedical technologies are safe, efficacious, and fit for intended use. The biggest roadblock to accomplishing this is medical device testing to determine the most appropriate regimen for the device and its use. Although speed to market is key, medical device manufacturers must devise and implement an…

iFyber participates in the 7th Bioengineering and Translational Medicine Conference in Boston from Wednesday, December 14, 2022 to Friday, December 16, 2022. The selection of suitable cell populations is crucial to the outcome of regenerative medicine. As a potential stem cell source, teeth are easily accessible, harbor several different cell populations, and yield rapidly growing…

iFyber is looking forward to talking with our wound care researcher friends this coming weekend in Las Vegas! Stop by and meet the team at booth 334.

iFyber is proud to share a publication with our client SweetBio: A Preliminary Direct Comparison of the Inflammatory Reduction and Growth Factor Production Capabilities of Three Commercially Available Wound Products: Collagen Sheet, Manuka Honey Sheet, and a Novel Bioengineered Collagen Derivative + Manuka Honey + Hydroxyapatite Sheet Learn more about it here: https://www.mdpi.com/1422-0067/23/18/10670/htm